Denes P, Uretz E, Ezri M D, Borbola J
Department of Medicine, Rush-Presbyterian-St Luke's Medical Center, Chicago, IL 60612.
Arch Intern Med. 1988 Sep;148(9):1922-8.
Unexplained syncope is a common medical problem. Intracardiac electrophysiologic studies (EPS) have been used to uncover the underlying arrhythmic mechanisms. Electrophysiologic studies are especially helpful in the management of patients with inducible tachyarrhythmias, but is of limited usefulness in those with normal EPS findings. We investigated whether clinical and noninvasive laboratory variables can predict the results of EPS in 89 patients with unexplained syncope. The prevalence of inducible ventricular tachycardia (VT) was 15%; supraventricular tachycardia, 15%; bradyarrhythmias, 41%; and normal EPS, 29%. We used multivariate discriminant function analysis to predict the results of EPS. The variables selected for identification of patients with inducible VT by this analysis include New York Heart Association (NYHA) functional class, gender, digitalis use, nonsustained VT, and atrial fibrillation. Based on our statistical model, performing EPS on 45% of the patients with unexplained syncope would result in a 90% sensitivity in detecting patients with inducible VT. The variables selected for identification of patients with normal EPS findings include: New York Heart Association functional class, heart disease, digitalis use, and intraventricular conduction. Based on this model, it would require that all but 12% of patients with unexplained syncope be studied to achieve a 90% predictive accuracy for identification of patients with normal EPS. During follow-up, recurrence rates for the different EPS categories did not differ significantly. The five-year cumulative survival among the EPS groups were as follows: VT, 37% +/- 28%; SVT, 90% +/- 9%; bradyarrhythmias, 71% +/- 10%; and normal EPS, 96% +/- 4%. Survival of the VT group differed significantly from that of the normal group. In patients with unexplained syncope, EPS findings can be predicted from clinical and noninvasive laboratory data. Mortality during follow-up relates to EPS findings.
不明原因晕厥是一个常见的医学问题。心内电生理研究(EPS)已被用于揭示潜在的心律失常机制。电生理研究对有可诱发的快速性心律失常的患者的治疗特别有帮助,但对EPS结果正常的患者作用有限。我们研究了临床和非侵入性实验室变量能否预测89例不明原因晕厥患者的EPS结果。可诱发室性心动过速(VT)的发生率为15%;室上性心动过速为15%;缓慢性心律失常为41%;EPS结果正常为29%。我们使用多变量判别函数分析来预测EPS结果。通过该分析选择用于识别可诱发VT患者的变量包括纽约心脏协会(NYHA)心功能分级、性别、洋地黄使用情况、非持续性VT和心房颤动。基于我们的统计模型,对45%的不明原因晕厥患者进行EPS检查,在检测可诱发VT的患者时敏感性将达到90%。选择用于识别EPS结果正常患者的变量包括:纽约心脏协会心功能分级、心脏病、洋地黄使用情况和室内传导。基于该模型,需要对除12%以外的所有不明原因晕厥患者进行研究,才能在识别EPS结果正常的患者时达到90%的预测准确率。在随访期间,不同EPS类别的复发率无显著差异。EPS各亚组的五年累积生存率如下:VT组为37%±28%;室上性心动过速(SVT)组为90%±9%;缓慢性心律失常组为71%±10%;EPS结果正常组为96%±4%。VT组的生存率与正常组有显著差异。在不明原因晕厥患者中,可从临床和非侵入性实验室数据预测EPS结果。随访期间的死亡率与EPS结果相关。